Use of prophylaxis to prevent complications of hemophilia

Advances in Experimental Medicine and Biology

Volumn 489, Issue , 2001, Pages 59-64

  Mannucci, P M ^a   Mendolicchio, L ^a   Gringeri, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTHROPATHY; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMOPHILIA; HOME CARE; HUMAN; INFANT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SUBSTITUTION THERAPY; SWEDEN; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FACTOR IX; FACTOR VIII; FEASIBILITY STUDIES; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HUMANS; INFANT; ITALY; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SWEDEN; UNITED STATES;

EID: 0035042013     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1277-6_5     Document Type: Article

References (15)

1. Hemophilia prophylaxis in Sweden
2. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophlia A and B
3. Prophylaxis with factor concentrates in preventing hemophilic arthropathy
4. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B
5. Central venous access devices in children with hemophilia: An up-date
6. Prot-A-Cath usage in children with haemophilia: Experience of 53 cases
7. Haemophilia prophylaxis in young patients. A long-term follow-up
8. Methods of hemophilia care delivery: Regular prophylaxis vs. episodic treatment
9. Haemophilia prophylaxis in the Netherlands
10. The impact of prophylactic treatment on children with severe haemophilia
11. Prophylaxis in children with hemophilia: Is it the optimal treatment?
12. Results of secondary prophylaxis in children with severe hemophilia
13. Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis
14. Socioeconomic impact of haemophilia care: Results of a pilot study
15. Prophylactic use of factor VIII: An economic evaluation